Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis. Issue 7 (13th June 2018)

• Record Type: Journal Article
• Authors: Lu, Tongyi; Wu, Binhua; Yu, Yunfei; Zhu, Wenhui; Zhang, Simin; Zhang, Yinmei; Guo, Jiaying; Deng, Ning
• Is Part Of: Cancer science. Volume 109:Issue 7(2018)
• Page Start: 2221
• Page End: 2234
• Publication Date: 2018-06-13
• Subjects: EMT -- ONECUT2 -- ovarian cancer -- siRNA -- tumor angiogenesis; Cancer -- Periodicals; Neoplasms -- Periodicals; Research -- Periodicals; Electronic journals; 616.994005
• DOI: 10.1111/cas.13633
• Languages: English
• ISSNs: 1347-9032

Abstract

Abstract : One cut homeobox 2 (ONECUT2 or OC‐2) is a newly discovered transcription factor. Aberrant expression of OC‐2 is closely related to cell proliferation, migration, invasion, and angiogenesis. In this study, we found that OC‐2 expression was upregulated in ovarian adenocarcinoma cells, by Western blot analysis. The results of immunohistochemistry showed that the expression of OC‐2 was also increased in malignant ovarian cancer tissue. In order to explore the role of OC‐2 in the development of ovarian cancer, siRNAs that specifically targets OC‐2 were designed. The siRNA targeting OC‐2 could effectively inhibit the vascular endothelial growth factor A (VEGFA) expression, but silence and overexpression of VEGFA did not affect OC‐2 expression. In addition, OC2‐siRNA could block the proliferation, migration, and invasion, and inhibit epithelial–mesenchymal transition and the AKT/ERK signaling pathway, of human ovarian cancer cells in vitro. In a mouse model of ovarian cancer xenograft tumors, OC2‐siRNA could significantly inhibit tumor cell growth and the tumor inhibition rate reached approximately 73%. The results of immunohistochemistry showed that the densities of microvessels stained with CD31, the expression of OC‐2 and VEGFA were significantly decreased in tumors. These data indicated that OC‐2 was an upstream regulator of VEGFA and silencing OC‐2 could inhibit ovarian cancer angiogenesis and tumor growth. Abstract : In this study, we found that the OC‐2 expression was up‐regulated in ovarian adenocarcinoma. OC2‐siRNA could block the proliferation, migration and invasion, and inhibit the AKT/ERK signaling pathway of human ovarian cancer cells. Our data indicated that OC‐2 was an upstream regulator of VEGF and silencing OC‐2 could inhibit ovarian cancer angiogenesis and tumor growth.